Cutera (NASDAQ:CUTR) updated its FY18 earnings guidance on Wednesday. The company provided EPS guidance of $1.03-1.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.00. The company issued revenue guidance of $178-181 million, compared to the consensus revenue estimate of $166.90 million.
Several equities analysts recently weighed in on the stock. Zacks Investment Research cut shares of Cutera from a hold rating to a sell rating in a research report on Monday, January 1st. BidaskClub raised shares of Cutera from a hold rating to a buy rating in a research report on Tuesday, December 12th. Finally, Maxim Group reaffirmed a hold rating on shares of Cutera in a research report on Wednesday, November 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Cutera currently has an average rating of Buy and an average price target of $37.33.
Cutera (NASDAQ CUTR) traded up $0.70 during trading on Thursday, hitting $46.65. 171,100 shares of the company’s stock traded hands, compared to its average volume of 171,513. Cutera has a 1 year low of $18.50 and a 1 year high of $52.90. The company has a market cap of $636.64, a PE ratio of 59.81, a P/E/G ratio of 1.37 and a beta of 0.41.
In other Cutera news, EVP Miguel Pardos sold 10,000 shares of Cutera stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $46.70, for a total transaction of $467,000.00. Following the transaction, the executive vice president now owns 39,698 shares of the company’s stock, valued at approximately $1,853,896.60. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director David B. Apfelberg sold 1,000 shares of Cutera stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $47.40, for a total transaction of $47,400.00. Following the transaction, the director now directly owns 8,259 shares in the company, valued at approximately $391,476.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 25,018 shares of company stock worth $1,147,316. Insiders own 11.60% of the company’s stock.
Cutera Company Profile
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.